Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
Completed
Conditions studied: Biomarkers
In brief
This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control.
Key facts
- Study ID
- NCT03173586
- Run by
- Harvard School of Public Health (HSPH)
- People needed
- 33000
- Starts
- 1999-09-16
- Expected to finish
- 2009-03-31
- Last updated by the study team
- 2017-06-02
Who can join
Age: 30 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- For the current study, we included participants who provided a blood sample and were previously selected as controls for nested case-control analyses of type 2 diabetes, coronary heart disease, stroke, colon cancer, colon polyps, pancreatic cancer, and breast cancer in the Nurse's Health Study.
You may not qualify if…
- Participants with self-reported prevalent diabetes or cardiovascular disease (CVD) at blood draw were excluded. After exclusions, a total of 8,492 individuals (6,961 from cycle 1 and 1,531 from cycle 2) with valid beverage intake data were included in the current analysis.
Where it is running
- Harvard T.H. Chan School of Public Health — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.